Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01386801 · ClinicalTrials.gov registry record
Multicenter Research Study to Build a Repository to Study Chronic Diseases in Indiana
A clinical trial of Diabetes Mellitus Type II, sponsored by Fairbanks Institute.
- Active
- Registry status
- 1,000
- Enrollment target
- 11
- Study locations
NCT01386801 is a study of Diabetes Mellitus Type II that is active but no longer recruiting, run by Fairbanks Institute. The registered enrollment target is 1,000 participants, above the 97-participant average among 7 other Diabetes Mellitus Type II trials with a reported enrollment target (931% higher). The trial reports 11 study locations across 1 state.
The verdict
NCT01386801, a study of Diabetes Mellitus Type II, is active but no longer recruiting, sponsored by Fairbanks Institute.
- ACTIVE NOT RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 11
- Study locations
Study Summary
Blood samples and health information (e.g., age at diagnosis, test results) are collected for the purposes of genetic research. The blood samples are assigned a number and stored in a repository for safe keeping until they are needed for a research project. Participants are persons who are healthy (not having high blood pressure, diabetes, or high cholesterol levels) or persons who have Diabetes Mellitus Type II(T2D) and live in Indiana. Participants complete a questionnaire at the time the blood sample is drawn. Visits are repeated at 2 and 5 years after initial contact. Researchers apply to the Fairbanks Institute for use of the blood samples and health information minus participant names and contact information. Their research is required to be related to find genes or substances made by genes that may be involved in Diabetes Mellitus Type II with the purpose of improving the investigators understanding of the illness potentially leading to the development of new diagnostic tools for identifying the illness, new treatments,or preventative measures.
Conditions Studied
Study Locations (11)
Indiana
- American Health Network - Avon
- Investigator's Research Group - Brownsburg
- American Health Network - Franklin
- American Health Network - Greenfield
- American Health Network - Indianapolis
- Krannert Cardiology - Indianapolis
- Oral Health Research Institute - Indianapolis
- IU School of Medicine/CTSI - Indianapolis (Downtown)
- Alivio Medical Center - Indianapolis (Spanish Speaking)
- IU Medical Group - Indianapolis (Spanish/English Speaking)
- American Health Network - Muncie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2009-12 |
| Est. Completion | 2050-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01386801
The ClinicalTrials.gov registry entry for NCT01386801 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 97-participant average among 7 other Diabetes Mellitus Type II trials with a reported enrollment target (931% higher). The listed sponsor is Fairbanks Institute, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Mellitus Type II appearing as the primary indexed condition, and to 0 interventions.
NCT01386801 reports 11 study locations spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT01386801 about?
NCT01386801 is a clinical study titled "Multicenter Research Study to Build a Repository to Study Chronic Diseases in Indiana". Blood samples and health information (e.g., age at diagnosis, test results) are collected for the purposes of genetic research. The blood samples are assigned a number and stored in a repository for safe keeping until they are needed for a research project. Participants are persons who are healthy (...
What is the current status of trial NCT01386801?
This trial is currently active not recruiting. The enrollment target is 1,000 participants. The study started on 2009-12. Estimated completion is 2050-06.
What conditions does trial NCT01386801 study?
This clinical trial studies the following conditions: Diabetes Mellitus Type II.
Who is sponsoring clinical trial NCT01386801?
This trial is sponsored by Fairbanks Institute, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01386801 being conducted?
This trial has 11 study locations across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus Type II
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
RECRUITING · NA
-
Evaluate HM-002-1005 in Subjects With Type 2 Diabetes Mellitus
COMPLETED · Phase 1
-
Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics
COMPLETED · Phase 4
-
Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus
COMPLETED · Phase 2
-
GOLO Open-Label Pilot 1
COMPLETED · NA
-
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.